Nuclear Medicine/Radiopharmaceuticals Market by Type (Therapeutic and Diagnostic), Procedures (Cardiovascular, Oncology, Central Nervous System, Skeletal, Endocrine, Gastrointestinal, Pulmonary, and Others), Application (Cardiology, Oncology, Thyroid, Neurology, and Others), and End User (Research Institutes, Hospitals, Diagnostic Centers, and Others), and By Region: Global Industry Perspective, Comprehensive Analysis and Forecast, 2024 - 2032

Global Nuclear Medicine/Radiopharmaceuticals market size earned around $5.59 Bn in 2023 and is expected to reach $11.46 Bn by 2032, with a CAGR of 8.3%.

全球核医学/放射性药物市场规模于2023年达到约55.9亿美元，预计到2032年将达到114.6亿美元，年复合增长率约为8.3%。